PortfoliosLab logoPortfoliosLab logo
RAPT vs. PZG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RAPT vs. PZG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RAPT Therapeutics, Inc. (RAPT) and Paramount Gold Nevada Corp. (PZG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


RAPT

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

PZG

1D
2.21%
1M
-3.47%
YTD
10.32%
6M
18.80%
1Y
135.59%
3Y*
68.61%
5Y*
5.97%
10Y*
-0.30%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RAPT vs. PZG - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
RAPT
RAPT Therapeutics, Inc.
71.30%167.96%-93.64%25.51%-46.09%85.97%-28.47%112.38%
PZG
Paramount Gold Nevada Corp.
10.32%268.42%-8.80%8.70%-50.62%-40.29%51.28%11.49%

Correlation

The correlation between RAPT and PZG is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Nov 1, 2019

0.07

Fundamentals

Market Cap

RAPT:

$1.56B

PZG:

$115.56M

EPS

RAPT:

-$3.92

PZG:

-$0.09

PB Ratio

RAPT:

10.29

PZG:

3.27

Total Revenue (TTM)

RAPT:

$0.00

PZG:

$0.00

Gross Profit (TTM)

RAPT:

-$200.00K

PZG:

-$892.14K

EBITDA (TTM)

RAPT:

-$108.01M

PZG:

-$11.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RAPT vs. PZG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RAPT

PZG
PZG Risk / Return Rank: 8282
Overall Rank
PZG Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
PZG Sortino Ratio Rank: 8484
Sortino Ratio Rank
PZG Omega Ratio Rank: 8080
Omega Ratio Rank
PZG Calmar Ratio Rank: 8181
Calmar Ratio Rank
PZG Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAPT vs. PZG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RAPT Therapeutics, Inc. (RAPT) and Paramount Gold Nevada Corp. (PZG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

RAPT vs. PZG - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


RAPTPZGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.91

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

Drawdowns

RAPT vs. PZG - Drawdown Comparison


Loading charts...

Drawdown Indicators


RAPTPZGDifference

Max Drawdown

Largest peak-to-trough decline

-93.81%

Max Drawdown (1Y)

Largest decline over 1 year

-51.31%

Max Drawdown (3Y)

Largest decline over 3 years

-51.31%

Max Drawdown (5Y)

Largest decline over 5 years

-74.05%

Max Drawdown (10Y)

Largest decline over 10 years

-90.14%

Current Drawdown

Current decline from peak

-68.55%

Average Drawdown

Average peak-to-trough decline

-68.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.42%

Volatility

RAPT vs. PZG - Volatility Comparison


Loading charts...

Volatility by Period


RAPTPZGDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.88%

Volatility (6M)

Calculated over the trailing 6-month period

56.82%

Volatility (1Y)

Calculated over the trailing 1-year period

71.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.64%

Dividends

RAPT vs. PZG - Dividend Comparison

Neither RAPT nor PZG has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RAPT vs. PZG - Financials Comparison

This section allows you to compare key financial metrics between RAPT Therapeutics, Inc. and Paramount Gold Nevada Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00K400.00K600.00K800.00K1.00M1.20M2022202320242025202600
(RAPT) Total Revenue
(PZG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RAPT and PZG have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for RAPT and PZG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer